Community Discussion
In our community we students of the market openly discuss our various market insights and thoughtful opinions in support of a wider understanding of price behavior. Join us and share your thoughts!
Latest Comments
Recent Posts
- Awaiting PDAC 2020 December 23, 2019
- Apple: Bottom Of 9th Inning November 19, 2019
- If Equities Drop, Just Add More November 18, 2019
- S&P 500 And 2015 November 11, 2019
- Not Trusting The A/D Line November 8, 2019
- Equity Markets Roll On Towards Euphoria November 6, 2019
- Alcoa: The Worst May Be Behind November 1, 2019
‘ and bingo was his name ‘! Bngo is getting fat !
novavax up ~40% today. biotech’s been rising since it received fast track approval for it’s ‘influenza vaccine’:
https://finviz.com/quote.ashx?t=NVAX
https://finance.yahoo.com/news/novavax-rises-fast-track-designation-145202959.html
Yeah… listen to the Sangamo CEO interview ( and posted) early last year… what caught my attention is when Sgmo CEO said ” if I were young and starting in this field ( gene editing ) today, I would go into Crispr research ” … good point, but Crispr is Sangamo’s biggest competition… I sold SGMO the next week….. will trade it only because their hemophilia A is now in Pfizer’s developmental clinical and Crisprs are not doing hemophilia, yet….This is Exactly why I say scientific journals Are the best source of information because any bias ( and there is… Read more »
When I read a super-hyped newsletter marketing headline like “No more diseases…” yada yada, I don’t waste time reading/listening to the pitch because I know that fewer than 1% contain anything of interest. However, if I occasionally think the content may be of interest, I google Stockgumshoe plus a few descriptors, and voila, there is usually some well-researched and objectively written material.
With this biotech promo, I did follow up with gumshoe and in the article, I found the writer’s views on the entire biotech industry to be informative. I think you’ll agree.
https://www.stockgumshoe.com/reviews/fda-trader/blancos-no-more-diseases-the-moment-the-world-stands-still-stock/
gm. Enerplus Corporation “. . exploration and development of crude oil and natural gas . .” https://finance.yahoo.com/news/enerplus-announces-2020-guidance-outlook-213500878.html
Baytex Energy (TSX, NYSE: BTE), which is my 2nd largest holding, announced its year-end 2019 reserves and 2019 Q4 and year-end prelim unaudited financial and operating results “Our production in 2019 exceeded the high end of our annual guidance with outstanding capital efficiencies in our development program. As a result, we generated $329 million of free cash flow and a 17% reduction in net debt. Each of our core properties (Eagle Ford, Viking and Heavy Oil) contributed substantial asset level free cash flow. We also achieved a strong year of reserves development with proved developed producing reserves increasing 5% with… Read more »
Equity market pull-back to start the week is widespread and international. Trouble in Davos? Virus in China?
As more and more viruses appear in human populations, mRna companies like Moderna will come to the rescue due to their speed ( vs egg based vaccines), precision and ability to adjust their uses as the viruses mutate… Moderna has big contracts with BARDA .
Toby… options at Srpt are starting to jump…… ?
Here on the Gold Coast of Florida, it’s 75F with mix of cloud and sun. Yesterday was sunny and 80+. Cocktails on the beach called for a mix of vodka, orange and cranberry. A needed time off. Meetings tomorrow.
Alamos Gold is best Goldminer performer today on Toronto and B2Gold is #3
I hold both.
Phase 2b underway
Cassava PTI 125 improved insulin receptors thru it’s Filamin scaffolding ” by normalizing signaling thru a7 ” … PTI 125 ” prevents and reverses the binding ofAB 42 to a7nAChe, and reduced tau phosphorylation and amyloid deposition “.. ” P-tauT -181 and neurogranin fell by more than 30% while inflammatory markers fell from 5 to 14 % “.. phase 2a
The circle of life Kaimu…. I was blessed to be with each of my parents on their last day on this earth. Love is the beginning and love is the ending… it’s all that really matters
Aloha! The ASX is in full swing this Sunday as the playoffs rumble on. I have to mention Silver Lake Res(SLR:ASX). This has been a 100% moneymaker as long as I have owned it. Up today some 10% on really good financials and an uptick in production guidance for FY2020. LINK: https://clients.weblink.com.au/news/pdf2/02193809.pdf Firing on all cylinders except that pesky “hedge”! But that is still an average $1900A gold price for the entire hedge, which is still profitable based on AISC numbers, but that is the risk when you hedge commodities. Still SLR has been a great run! Only one better… Read more »
Aloha! Bill and all many mahalos for the well wishes. The most amazing part of watching my Mother be 92 is how child like she has become and how I have become the “parent”! It is a blessing and a curse. Her independence has given way to innocence. It must be some sort of aura because I see nurses comment on how cute she is as if they are looking at a child.
It is an honor and my chosen duty to take care of her.
kaimu, We’ve been good friends for 10 years so my wife and I are hoping your mother achieves the best possible outcome. A year after I started blogging, my mother discovered stage 3 colon cancer. After watching many sisters and brothers die of this disease, she declined chemo in order to live her final months as good as possible. But fairly soon after, she was hospitalized and started taking opium, which eliminated any quality of life. Unfortunately, back then, cannabis-based drugs were not approved. So, if any of our family faces such an end, I expect them to be taking… Read more »
right Kaimu, with big pharma subsidizing doctors not surprising though. its horrifying
to find your mom suffering like that. thankfully she is doing better, God bless.
I am honestly looking for a bid from Novartis of $ 22 billion dollars ( US ) for Sarepta Therapeutics after the Sarepta-Roche, SRP- 9001 DMD sales agreement is closed in the first quarter of this year. Several analysts say the Roche premium payed takes Sarepta off the merger screen. I respectfully disagree . Sarepta will now have over $ 2 Billion in cash and Roche/Sarepta will split development costs/profits of SRP – 9001 down the middle. With the multitude of other programs in Sarepta’s pipeline and $ 500 Million yearly revenues, what’s not to like ? .. I believe… Read more »
Kaimu… nothing stronger than the love of a mother and child…